The Collaboration Project between the Ministry of Science and Technology (MOST) Taiwan and Janssen Biotech, Inc. (one of the Janssen Pharmaceutical Companies of Johnson & Johnson), the first academia-industry collaboration that Taiwan has forged with a global pharmaceutical company, is bringing funding and focus to specific disease areas.
 
							 
														 
														 
														 
														 
														 
														